The effect of long-term exposure to low doses of endocrine disruptor ddt on serum levels of thyroid protein autoantigenes and antithyroid autoantibodies
Yaglova N.V.1 , Yaglov V.V.1
1. Research Institute of Human Morphology, Moscow, Russia
Changes in secretion of thyroid autoantigenes and production of antithyroid autoantibodies after long-term exposure to low doses of DDT were studied. Changes in serum levels of antithyroid peroxidase antibodies and thyroid peroxidase, attributed to disruption of thyroxine production by DDT were found. Long-term exposure of rats to low doses of DDT revealed no specific impact on serum autoantibodies to all thyroid autoantigenes studied. The increase of the ratio of autoantibody/autoantigen for thyroid peroxidase and thyroglobulin was rather small and thus could not be considered as a significant symptom of thyroid autoimmunity.
Yaglova N.V., Yaglov V.V. (2016) The effect of long-term exposure to low doses of endocrine disruptor ddt on serum levels of thyroid protein autoantigenes and antithyroid autoantibodies. Biomeditsinskaya Khimiya, 62(1), 73-78.
Yaglova N.V. et al. The effect of long-term exposure to low doses of endocrine disruptor ddt on serum levels of thyroid protein autoantigenes and antithyroid autoantibodies // Biomeditsinskaya Khimiya. - 2016. - V. 62. -N 1. - P. 73-78.
Yaglova N.V. et al., "The effect of long-term exposure to low doses of endocrine disruptor ddt on serum levels of thyroid protein autoantigenes and antithyroid autoantibodies." Biomeditsinskaya Khimiya 62.1 (2016): 73-78.
Yaglova, N. V., Yaglov, V. V. (2016). The effect of long-term exposure to low doses of endocrine disruptor ddt on serum levels of thyroid protein autoantigenes and antithyroid autoantibodies. Biomeditsinskaya Khimiya, 62(1), 73-78.
References
United States Department of Health and Human Services Progress in Autoimmune Diseases Research, Report to Congress, National Institutes of Health, The Autoimmune Diseases Coordinating Committee (2005) 146p. Scholar google search
Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W., Gunter E., Spencer C., Braverman L. (2002) J. Clin. Endocrinol. Metab., 87, 489-499. CrossRef Scholar google search
Patrick L. (2009) Alternative Medicine Review, 14(4), 326-346. Scholar google search
State of the Science of Endocrine Disrupting Chemicals – 2012. An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme (UNEP) and WHO (2013) 296p. Scholar google search
Yaglov V.V., Yaglova N.V. (2014) Sovremennye tekhnologii v meditsine, 6(4), 55-61. Scholar google search
National Toxicology Program (2001) National Toxicology Program’s report of the endocrine disruptors low dose peer review. Research Triangle Park, NC: National Institute of Environmental Health Sciences. Scholar google search
Vandenberg L., Colborn T., Hayes T., Heindel J., Jacobs D. Jr., Lee D.-H., Shioda T., Soto A., vom Saal F., Welshons W., Zoeller T., Myers J. (2012) Endocrine Reviews, 33(3), 378-455. CrossRef Scholar google search
Gigienicheskie trebovaniya bezopasnosti i pishchevoj tsennosti pishchevykh produktov (2008) SanPin 2.3.2.1078-01. Scholar google search
McLachlan S., Rapoport B. (1992) Endocrine Reviews, 13, 192-206. Scholar google search
Yoshida H., Amino N., Yagawa K., Uemura K., Satoh M., Miyai K., Kumahara Y. (1978) J. Clin. Endocrinol. Metab., 46, 859-862. CrossRef Scholar google search
Jansson R., Thompson P., Clark F, McLachlan S. (1986) Clin. Exp. Immunol., 63, 80-86. Scholar google search
Freire C., Koifman R., Novaes Sarcinelli P., Simoes Rosa A., Clapauch R., Koifman S. (2014) Environm. Res., 217, 370-378. Scholar google search
Langer P., Tajtakova M., Kocan A., Drobna B., Kostalova L., Fodor G., Klimes I. (2012) Endocr. Regul., 46, 191-203. CrossRef Scholar google search